Related Experiment Videos
Leptin, estrogens and cancer.
María del Carmen Maeso Fortuny1, Buenaventura Brito Díaz, Antonio Cabrera de León
1Unidad de investigación, Hospital de La Candelaria, Santa Cruz de Tenerife, Spain. antonio.cabreradeleon@gobiernodecanarias.org
Mini Reviews in Medicinal Chemistry
|August 22, 2006
Summary
Obesity causes leptin resistance, blocking key cellular pathways. This promotes lipid buildup and estrogen activity, potentially driving cancer through the MAPK/MEK/ERK signaling cascade.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Obesity is characterized by leptin resistance, affecting cellular signaling.
- Leptin receptor and JAK-STAT pathway inhibition are central to this resistance.
Purpose of the Study:
- To elucidate the molecular mechanisms linking obesity-induced leptin resistance to oncogenesis.
- To identify the specific cellular pathways involved in obesity-related cancer risk.
Main Methods:
- Analysis of cellular signaling pathways in obesity models.
- Investigation of lipid metabolism and estrogen cycle alterations in adipocytes.
- Examination of the role of MAPK, MEK, and ERK pathways.
Main Results:
- Obesity leads to blocked leptin receptor and JAK-STAT pathways.
- Increased intracellular lipid metabolites and adipocyte non-oxidative metabolism observed.
- Stimulation of the cell estrogen cycle identified as a consequence.
- Potential oncogenic role of these factors via the MAPK/MEK/ERK pathway confirmed.
Conclusions:
- Leptin resistance in obesity creates a pro-oncogenic cellular environment.
- The MAPK/MEK/ERK pathway is a critical mediator linking obesity to cancer risk.
- Understanding these pathways may offer novel therapeutic targets for obesity-related cancers.